The Division has a number of major externally awarded projects. In addition, we are linked to the King’s British Heart Foundation Centre of Excellence.
The Division of Imaging is the research arm of King’s Health Partner’s Imaging and Biomedical Engineering Clinical Academic Group, also headed by Professor Reza Razavi. Imaging Sciences is a also a research theme of the GSTT and King’s NIHR Biomedical Research Centre.
The Comprehensive Cancer Imaging Centre
The focus of the centre is on using imaging techniques to identify appropriate treatments in diagnosed cancer patients. Read more
Medical Engineering Centre
The King’s College London Medical Engineering Centre (MEC), funded by the Wellcome Trust and EPSRC, aims to break down the barriers between biology, medicine, and the fields of engineering, physics, mathematics, computer science and chemistry. Visit MEC webpages.
Centre for Developing Brain
The goal of the Centre for the Developing Brain is to reduce the number of children who suffer brain damage in the perinatal period through understanding human brain development around the time of birth; creating new capabilities to map cerebral development in health and disease; exploring and exploiting the underlying biology of brain development disorder to create new therapies; conducting clinical trials of novel neuroprotective and neural rescue therapies. Visit Centre for Developing Brain webpages.
Force, Imaging the FORCE of Cancer, is a 4 year project funded by the European Commission, via Horizon 2020. Cancer is the second leading cause of mortality in EU member states with ~90% of all cancer deaths caused by metastatic spread. Despite its significance, measuring metastatic potential as well as potential indicators of therapy efficacy remain unmet clinical challenges.
The FORCE project aims to address this challenge and to provide new tools and strategies for planning and monitoring cancer treatment by measuring the forces active in cancer. During the project, the biomechanical properties of the tumour and its neighbouring tissue will be measured via MR-elastography; resultant images will be used to reconstruct images of the internal and external forces acting on the tumour. We call this novel imaging modality Magnetic Resonance Force (MRF) imaging. Visit project website.
The role of King's Technology Evaluation Centre is to support the work of the Medical Technologies Evaluation Programme (MTEP) and the Diagnostic Assessment Programme (DAP) of the National Institute for Health and Care Excellence (NICE). MTEP selects and evaluates innovative medical technologies (including devices and diagnostics) and helps the NHS adopt efficient and cost effective medical devices and diagnostics more rapidly and consistently. Visit KiTEC webpage.
TOHETI stands for Transforming Outcomes and Health Economics Through Imaging and is a large scale, innovative programme engaging NHS partners across Lambeth and Southwark to develop a vision for the future of imaging, with patient experience and outcome at its core. By changing the use of imaging in the patient pathway, TOHETI aims to show how imaging can be used more effectively as a diagnostic and therapeutic tool across a range of common patient pathways, as well as contributing to cost-effectiveness across King’s Health Partners. Visit TOHETI website.
iFIND (intelligent Fetal Imaging and Diagnosis) is an exciting multi-disciplinary project which proposes to improve antenatal ultrasound scanning. We propose to do this by developing new computer guided ultrasound technologies that will allow screening of fetal abnormalities in an automated and uniform fashion. Visit iFIND website.
The primary aim of VP2HF is to bring together image and data processing tools with statistical and integrated biophysical models mainly developed in previous VPH projects, into a single clinical workflow to improve therapy selection and treatment optimization in HF. Visit VP2HF website